摘要
Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide synthase and is independently associated with poor cardiovascular outcomes. However, the direct relationship between serum ADMA level and the extent of subclinical coronary atherosclerotic plaque has never been investigated. In total, 130 consecutive asymptomatic Taiwanese subjects (mean age, 55.6±10 years), who received a health screening evaluation, were enrolled. Coronary plaque detected by computed tomography coronary angiography (CTCA) was observed in 85 (65.4%) of 130 individuals. Patients with coronary plaque had a higher ADMA level (1.16±1.15 μmol/L vs. 0.42 ± 0.33 μmol /L, p
原文 | 英語 |
---|---|
頁(從 - 到) | 236-243 |
頁數 | 8 |
期刊 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry |
卷 | 12 |
發行號 | 3 |
DOIs | |
出版狀態 | 已發佈 - 2012 |
ASJC Scopus subject areas
- 內分泌學、糖尿病和代謝
- 免疫學和過敏
- 藥理